Back to Search
Start Over
RLN3/RXFP3 Signaling in the PVN Inhibits Magnocellular Neurons via M-like Current Activation and Contributes to Binge Eating Behavior
- Source :
- The Journal of Neuroscience
- Publication Year :
- 2020
- Publisher :
- Society for Neuroscience, 2020.
-
Abstract
- Binge-eating disorder is the most common eating disorder. Various neuropeptides play important roles in the regulation of feeding behavior, including relaxin-3 (RLN3), which stimulates food intake in rats through the activation of the relaxin-family peptide-3 receptor (RXFP3). Here we demonstrate that a likely mechanism underlying the orexigenic action of RLN3 is RXFP3-mediated inhibition of oxytocin- and arginine-vasopressin-synthesizing paraventricular nucleus (PVN) magnocellular neurosecretory cells. Moreover, we reveal that, in male and female rats, this action depends on M-like potassium conductance. Notably, higher intra- and peri-PVN RLN3 fiber densities were observed in females, which may constitute an anatomic substrate for observed sex differences in binge-eating disorder. Finally, in a model of binge-eating in female rats, RXFP3 blockade within the PVN prevented binge-eating behavior. These data demonstrate a direct RLN3/RXFP3 action in the PVN of male and female rats, identify the associated ionic mechanisms, and reveal that hypothalamic RLN3/RXFP3 signaling regulates binge-eating behavior. SIGNIFICANCE STATEMENT Binge-eating disorder is the most common eating disorder worldwide, affecting women twice as frequently as men. Various neuropeptides play important roles in the regulation of feeding behavior, including relaxin-3, which acts via the relaxin-family peptide-3 receptor (RXFP3). Using a model of binge-eating, we demonstrated that relaxin-3/RXFP3 signaling in the hypothalamic paraventricular nucleus (PVN) is necessary for the expression of binge-eating behavior in female rats. Moreover, we elucidated the neuronal mechanism of RLN3/RXFP3 signaling in PVN in male and female rats and characterized sex differences in the RLN3 innervation of the PVN. These findings increase our understanding of the brain circuits and neurotransmitters involved in binge-eating disorder pathology and identify RXFP3 as a therapeutic target for binge-like eating disorders.
- Subjects :
- Male
0301 basic medicine
endocrine system
medicine.medical_specialty
Potassium Channels
Receptors, Peptide
relaxin-3
Neuropeptide
Nerve Tissue Proteins
Biology
Receptors, G-Protein-Coupled
03 medical and health sciences
0302 clinical medicine
binge eating
Internal medicine
Orexigenic
medicine
Animals
Bulimia
Receptor
Research Articles
RXFP3
Neurons
Sex Characteristics
Behavior, Animal
Binge eating
General Neuroscience
Relaxin
digestive, oral, and skin physiology
Feeding Behavior
M-like current
Rats
030104 developmental biology
Endocrinology
Oxytocin
Paraventricular nucleus of hypothalamus
paraventricular nucleus of hypothalamus
Magnocellular cell
Female
medicine.symptom
Relaxin-3
hormones, hormone substitutes, and hormone antagonists
030217 neurology & neurosurgery
Cellular/Molecular
Paraventricular Hypothalamic Nucleus
Signal Transduction
medicine.drug
Subjects
Details
- ISSN :
- 15292401 and 02706474
- Volume :
- 40
- Database :
- OpenAIRE
- Journal :
- The Journal of Neuroscience
- Accession number :
- edsair.doi.dedup.....e630151751867d1053e6b6fc1298c755